Hatem Sallam

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

Karima Bettayeb, Hatem Sallam, Yoan Ferandin et al. · Molecular Cancer Therapeutics · 2008 · 54 citations

LIVER CIRCADIAN CLOCK, A PHARMACOLOGIC TARGET OF CYCLIN-DEPENDENT KINASE INHIBITOR SELICICLIB

Ida Iurisci, Elisabeth Filipski, Hatem Sallam et al. · Chronobiology International · 2009 · 35 citations

Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro

Hairong Song, Marina Vita, Hatem Sallam et al. · Cancer Chemotherapy and Pharmacology · 2007 · 22 citations

Hematological Malignancy, Cdk-inhibitor Roscovitine, Malignant Blood Disorder +9

The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model

Hatem Sallam, Ahmed T. El‐Serafi, Elisabeth Filipski et al. · Chronobiology International · 2015 · 22 citations

Chemoprevention Strategy, Pathology, Pharmacotherapy +20

Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasis

Hollie Burrell‐Saward, A. I. Harris, Raul de LaFlor et al. · International Journal of Antimicrobial Agents · 2017 · 15 citations

Human African Trypanosomiasis, Biochemistry, Antiparasitic Agent +13